The Evaluation of Oral Health in Patients with Chronic Kidney Disease – A Longitudinal Study
Mimoza Canga,
Irene Malagnino,
Edit Xhajanka,
Rozela Xhemnica,
Vergjini Mulo,
Vito Antonio Malagnino
Issue:
Volume 9, Issue 1, March 2023
Pages:
1-5
Received:
20 December 2022
Accepted:
6 January 2023
Published:
17 January 2023
Abstract: Background: Chronic kidney disease affects more than 10% of people globally. The aim of the study was to assess oral health in patients with chronic kidney disease. The sample was composed of 233 patients, of which 147 (63%) were males and 86 (37%) were females. Participants' age varied from 31 to 70 years old. We divided the participants into four age groups: 31-40, 41-50, 51-60, and 61-70 years old. Data were analyzed by using (IBM, New York, USA, SPSS Statistics for Windows), Version 23.0. The significance level (α) was set at 0.05, with a confidence interval (CI) of 95%. The prevailing age range was from 51 to 60 years old, with 31.8% of the participants. A considerable number of patients with chronic kidney disease had low incomes, respectively 42.4% of them. 80.7% of the patients were current smokers and 73.4% of them consumed alcohol. A large proportion of respondents 83.7% of them were diabetic patients. 63.1% of the participants reported that they had hypertension. According to our findings, 55.8% of the participants brush their teeth only once a day. The study found a strong correlation between chronic kidney disease and diabetes mellitus (CI 95; 1.17-1.33, P-value ˂.0001), hypertension (P ˂.0001), alcohol consumption (P=.001), and smoking (P =.000). Gingivitis was the most common oral disease which affected 73.4% of the participants, followed by 56.7% of them who had dental caries.
Abstract: Background: Chronic kidney disease affects more than 10% of people globally. The aim of the study was to assess oral health in patients with chronic kidney disease. The sample was composed of 233 patients, of which 147 (63%) were males and 86 (37%) were females. Participants' age varied from 31 to 70 years old. We divided the participants into four...
Show More
Therapy Against COVID-19: Medicinal Plant Extracts Can Be a Solution
Bouopda Tamo Sylvain Parfait,
Mundene-Timothee Junior Lawrence
Issue:
Volume 9, Issue 1, March 2023
Pages:
6-13
Received:
19 April 2022
Accepted:
13 May 2022
Published:
31 March 2023
Abstract: Coronavirus disease 2019 (COVID-19) was declared by the World Health Organization (WHO) as a pandemic on March 11, 2020. Despite the development of anti-COVID-19 vaccine, the disease continues to kill thousands of people, mainly due to a lack of sufficient doses for all populations and to the prioritization of populations to be vaccinated. According to epidemiological data from April 06, 2022, the COVID-19 pandemic has already killed more than 6,184,299 people around the world with nearly 494,286,073confirmed cases. To date, no antiviral drug has been officially approved to fight this pandemic. Medical professionals and researchers all over the globe are in pursuit for the discovery therapies against this disease. One of the strategies is the use of medicinal plants. Indeed, plant extracts can inhibit viral growth and their effectiveness has been demonstrated on many viruses encountered in human pathology including SARS-CoV-1, poliovirus, varicella-zoster virus, HIV, human papillomavirus, HSV-1, HSV-2, influenza virus, cytomegalovirus and many others. Besides, it has been shown that plant extracts can regulate immune system and make the body able to prevent the establishment of viral infection or to fight against its deleterious effects. The exploration of plant extracts with anti-viral and immunostimulatory properties could be exploitable in the development of drug against COVID-19. This review promotes medicinal plant extracts as potential anti-COVID-19 drugs.
Abstract: Coronavirus disease 2019 (COVID-19) was declared by the World Health Organization (WHO) as a pandemic on March 11, 2020. Despite the development of anti-COVID-19 vaccine, the disease continues to kill thousands of people, mainly due to a lack of sufficient doses for all populations and to the prioritization of populations to be vaccinated. Accordin...
Show More
